Physician profile
John A Bowers
NPI 1811919665
$11,833.85
in general payments reported to CMS, 2019-2025
35 companies · $2,363 in 2025
The $2,363 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2020: $705 · 2021: $1,938 · 2022: $1,443 · 2023: $2,612 · 2024: $1,468 · 2025: $2,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,368 · Travel and Lodging: $1,013 · Education: $61.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,368.21 |
| Travel and Lodging | $1,013.00 |
| Education | $61.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,917.94 | 2019-2025 | Impella |
| Medtronic, INC. | $1,541.79 | 2024-2025 | Symplicity G3, Ffrangio |
| Abbott Laboratories | $1,253.43 | 2019-2023 | Cardiomems, Gallant, Aveir |
| Merck Sharp & Dohme LLC | $898.86 | 2021-2025 | Verquvo, Capvaxive, Winrevair |
| Amgen INC. | $787.86 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $778.23 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $743.26 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $449.41 | 2019-2025 | General - Pain Management, Watchman Flx, Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $432.11 | 2019-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $400.73 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $346.18 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $344.86 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $255.17 | 2019-2023 | |
| Pfizer INC. | $225.92 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $212.82 | 2023-2024 | Inpefa |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $174.90 | 2023 | |
| Penumbra, INC. | $142.85 | 2023 | Indigo System |
| Cardiovascular Systems INC. | $111.81 | 2019-2023 | Diamondback Coronary |
| Merit Medical Systems INC | $110.34 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $110.21 | 2019-2020 | |
| Biotronik INC. | $68.28 | 2020-2021 | |
| Novo Nordisk INC | $59.76 | 2023-2024 | Ozempic, Rybelsus |
| Bridgebio Pharma, INC. | $57.26 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $54.33 | 2024 | Arcalyst |
| Cvrx, INC. | $53.77 | 2021 | |
| Heartflow, INC. | $50.00 | 2023 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $46.89 | 2025 | Farxiga |
| Philips North America LLC | $40.75 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $36.46 | 2019-2025 | Evkeeza |
| Esperion Therapeutics, INC. | $33.45 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.49 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $17.84 | 2021 | |
| Medtronic Vascular, INC. | $15.53 | 2019 | |
| Teleflex LLC | $15.37 | 2022 | |
| Tactile Systems Technology INC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.